EW
$168.41
Edwards Lifesciences
$9.30
5.85%
EW
Earnings Whisper ®
$1.20
4th Quarter December 2018
Consensus:  $1.17
Revenue:  $973.72 Mil
Thursday
Jan 31
4:15 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Tuesday, October 23, 2018

What do you expect when EW reports earnings?
Beat
Meet
Miss

Where is EW's stock price going from here?
Up
Flat
Down
Stock chart of EW
Analysts
Summary of analysts' recommendations for EW
Score
Grade
Pivots
Resistance
$176.08
$172.30
$170.36

$166.58

Support
$164.64
$160.86
$158.92
Tweet
Growth
Description
Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.
Peers
Wright Medical GroupAlign TechnologyIntuitive SurgicalSTERISInvacareCryoLifeRTI SurgicalLakeland Industries